Jump to section
To proactively challenge the current status quo for those living with cancer and change perceptions about life after treatment.
1,000 people are diagnosed with cancer in the UK every day, and confusing and uncoordinated healthcare systems have left many patients feeling lost. Perci is revolutionising the way long-term support is provided for people living with cancer, providing tailored answers and access to high-quality cancer professionals to empower cancer and post-cancer patients to make the best decisions about their health and well-being.
The company initially found success by unlocking reimbursement models for care through employers and insurers and exploring how best to support NHS treatment facilities. Perci has since grown to offer a range of programmes that provide support across the whole cancer continuum, from preparing for treatment, to support during treatment, recovery and rehabilitation, and help to return to work.
Following an impressive Octopus Ventures-led seed round, Perci is focused on further investing in its technology roadmap, team expansion, and pursuing partnerships with large employers and insurers to grow access and visibility for cancer patients.
Kirsty
Company Specialist at Welcome to the Jungle
Apr 2023
$4.4m
SEED
Jul 2021
$1.9m
SEED
This company has top investors
Kelly McCabe
(CEO)Former COO of the London Stock Company. Worked at Leaders in Oncology Care in various roles including COO and Head of Dietetics & Therapies..
Morgan Fitzsimons
(CXO)Board Trustee at Jo's Cervical Cancer Trust. Former CMO at London Stock Company, Global Head of Engagement Management at ASOS.com, and Director of Digital Marketing at CBS.